274 related articles for article (PubMed ID: 27002182)
41. Analysis of specific interactions of native protein phosphatase 1 isoforms with targeting subunits.
Colbran RJ; Carmody LC; Bauman PA; Wadzinski BE; Bass MA
Methods Enzymol; 2003; 366():156-75. PubMed ID: 14674248
[TBL] [Abstract][Full Text] [Related]
42. Identification of an essential acidic residue in Cdc25 protein phosphatase and a general three-dimensional model for a core region in protein phosphatases.
Eckstein JW; Beer-Romero P; Berdo I
Protein Sci; 1996 Jan; 5(1):5-12. PubMed ID: 8771191
[TBL] [Abstract][Full Text] [Related]
43. Crystal structure and functional analysis of the SurE protein identify a novel phosphatase family.
Lee JY; Kwak JE; Moon J; Eom SH; Liong EC; Pedelacq JD; Berendzen J; Suh SW
Nat Struct Biol; 2001 Sep; 8(9):789-94. PubMed ID: 11524683
[TBL] [Abstract][Full Text] [Related]
44. Molecular basis for TPR domain-mediated regulation of protein phosphatase 5.
Yang J; Roe SM; Cliff MJ; Williams MA; Ladbury JE; Cohen PT; Barford D
EMBO J; 2005 Jan; 24(1):1-10. PubMed ID: 15577939
[TBL] [Abstract][Full Text] [Related]
45. Crystal structure of human dual specificity phosphatase, JNK stimulatory phosphatase-1, at 1.5 A resolution.
Yokota T; Nara Y; Kashima A; Matsubara K; Misawa S; Kato R; Sugio S
Proteins; 2007 Feb; 66(2):272-8. PubMed ID: 17068812
[TBL] [Abstract][Full Text] [Related]
46. Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells.
Teruya T; Simizu S; Kanoh N; Osada H
FEBS Lett; 2005 Apr; 579(11):2463-8. PubMed ID: 15848189
[TBL] [Abstract][Full Text] [Related]
47. Identification and characterization of a novel protein inhibitor of type 1 protein phosphatase.
Shirato H; Shima H; Sakashita G; Nakano T; Ito M; Lee EY; Kikuchi K
Biochemistry; 2000 Nov; 39(45):13848-55. PubMed ID: 11076525
[TBL] [Abstract][Full Text] [Related]
48. Multiple structural elements define the specificity of recombinant human inhibitor-1 as a protein phosphatase-1 inhibitor.
Endo S; Zhou X; Connor J; Wang B; Shenolikar S
Biochemistry; 1996 Apr; 35(16):5220-8. PubMed ID: 8611507
[TBL] [Abstract][Full Text] [Related]
49. Structural and binding studies of the three-metal center in two mycobacterial PPM Ser/Thr protein phosphatases.
Wehenkel A; Bellinzoni M; Schaeffer F; Villarino A; Alzari PM
J Mol Biol; 2007 Dec; 374(4):890-8. PubMed ID: 17961594
[TBL] [Abstract][Full Text] [Related]
50. Preparation and characterization of recombinant protein phosphatase 1.
Watanabe T; da Cruz e Silva EF; Huang HB; Starkova N; Kwon YG; Horiuchi A; Greengard P; Nairn AC
Methods Enzymol; 2003; 366():321-38. PubMed ID: 14674258
[No Abstract] [Full Text] [Related]
51. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.
Li YM; Mackintosh C; Casida JE
Biochem Pharmacol; 1993 Oct; 46(8):1435-43. PubMed ID: 8240393
[TBL] [Abstract][Full Text] [Related]
52. Overexpression and purification of human calcineurin alpha from Escherichia coli and assessment of catalytic functions of residues surrounding the binuclear metal center.
Mondragon A; Griffith EC; Sun L; Xiong F; Armstrong C; Liu JO
Biochemistry; 1997 Apr; 36(16):4934-42. PubMed ID: 9125515
[TBL] [Abstract][Full Text] [Related]
53. Cantharidin-based small molecules as potential therapeutic agents.
Puerto Galvis CE; Vargas Méndez LY; Kouznetsov VV
Chem Biol Drug Des; 2013 Nov; 82(5):477-99. PubMed ID: 23809227
[TBL] [Abstract][Full Text] [Related]
54. The 35 kDa acid metallophosphatase of the frog Rana esculenta liver: studies on its cellular localization and protein phosphatase activity.
Szalewicz A; Strzelczyk B; Sopel M; Kubicz A
Acta Biochim Pol; 2003; 50(2):555-66. PubMed ID: 12833181
[TBL] [Abstract][Full Text] [Related]
55. Crystal structures of protein phosphatase-1 bound to motuporin and dihydromicrocystin-LA: elucidation of the mechanism of enzyme inhibition by cyanobacterial toxins.
Maynes JT; Luu HA; Cherney MM; Andersen RJ; Williams D; Holmes CF; James MN
J Mol Biol; 2006 Feb; 356(1):111-20. PubMed ID: 16343532
[TBL] [Abstract][Full Text] [Related]
56. Development of a Substrate Identification Method for Human Scp1 Phosphatase Using Phosphorylation Mimic Phage Display.
Otsubo K; Yoneda T; Kaneko A; Yagi S; Furukawa K; Chuman Y
Protein Pept Lett; 2018; 25(1):76-83. PubMed ID: 29210629
[TBL] [Abstract][Full Text] [Related]
57. Structural role of a conserved active site cis proline in the Thermotoga maritima acetyl esterase from the carbohydrate esterase family 7.
Singh MK; Manoj N
Proteins; 2017 Apr; 85(4):694-708. PubMed ID: 28097692
[TBL] [Abstract][Full Text] [Related]
58. Insights derived from the structures of the Ser/Thr phosphatases calcineurin and protein phosphatase 1.
Lohse DL; Denu JM; Dixon JE
Structure; 1995 Oct; 3(10):987-90. PubMed ID: 8590008
[TBL] [Abstract][Full Text] [Related]
59. Identification of a novel phosphatidic acid binding domain in protein phosphatase-1.
Jones JA; Rawles R; Hannun YA
Biochemistry; 2005 Oct; 44(40):13235-45. PubMed ID: 16201749
[TBL] [Abstract][Full Text] [Related]
60. An Ultra-High-Throughput Screen for Catalytic Inhibitors of Serine/Threonine Protein Phosphatases Types 1 and 5 (PP1C and PP5C).
Swingle M; Volmar CH; Saldanha SA; Chase P; Eberhart C; Salter EA; D'Arcy B; Schroeder CE; Golden JE; Wierzbicki A; Hodder P; Honkanen RE
SLAS Discov; 2017 Jan; 22(1):21-31. PubMed ID: 27628691
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
